Grants per year
Personal profile
Research Interests
Personalized Cancer Therapy, Precision Medicine, Early Phase Clinical Trials, First-in-Human Study, Novel Combination Cancer Therapy, Targeted therapy, Immunotherapy, Biomarker Study, Novel Drug Development, Novel Drug Delivery System, Adaptive Clinical Trials Design, Cell Signaling Pathway, Immune Checkpoint Pathway
Training Experience
| 2011 | Residency, Albert Einstein Medical Center |
| 2014 | Fellowship, University of Texas/MD Anderson Cancer Center |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MBA, Johns Hopkins University
… → 2007
MPH, Johns Hopkins University
… → 2007
MD, Seoul National University
… → 2002
Research interests
- Oncology
Fingerprint
Dive into the research topics where Young Kwang Chae is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #RMC-4630-02: A Phase 1b/2, Open-Label, Multicenter Dose-Escalation and Dose-Expansion Study of the Combination of RMC-4630 with Cobimetinib in Adult Participants with Relapsed/Refractory Solid Tumors and a Phase 1b Study of RMC-4630 with Osimertinib
PPD Investigator Services, LLC, Revolution Medicines, Inc.
7/7/20 → 7/7/23
Project: Research project
-
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
Zhang, B., Chae, Y. K., Fang, D., Sosman, J. A. & Zou, L.
5/15/20 → 4/30/26
Project: Research project
-
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
Adams, S., Othus, M., Patel, S. P., Miller, K. D., Chugh, R., Schuetze, S. M., Chamberlin, M. D., Haley, B. J., Storniolo, A. M. V., Reddy, M. P., Anderson, S. A., Zimmerman, C. T., O’Dea, A. P., Mirshahidi, H. R., Ahnert, J. R., Brescia, F. J., Hahn, O., Raymond, J. M., Biggs, D. D., Connolly, R. M., & 8 others, Jan 15 2022, In: Clinical Cancer Research. 28, 2, p. 271-278 8 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Artificial Intelligence-based Radiomics in the Era of Immuno-oncology
Kang, C. Y., Duarte, S. E., Kim, H. S., Kim, E., Park, J., Lee, A. D., Kim, Y., Kim, L., Cho, S., Oh, Y., Gim, G., Park, I., Lee, D., Abazeed, M., Velichko, Y. S. & Chae, Y. K., Jun 8 2022, In: The oncologist. 27, 6, p. e471-e483Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Artificial Intelligence–Powered Hematoxylin and Eosin Analyzer Reveals Distinct Immunologic and Mutational Profiles among Immune Phenotypes in Non–Small-Cell Lung Cancer
Park, J., Cho, H. G., Park, J., Lee, G., Kim, H. S., Paeng, K., Song, S., Park, G., Ock, C. Y. & Chae, Y. K., Apr 2022, In: American Journal of Pathology. 192, 4, p. 701-711 11 p.Research output: Contribution to journal › Article › peer-review
-
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial
Kim, E. S., Velcheti, V., Mekhail, T., Yun, C., Shagan, S. M., Hu, S., Chae, Y. K., Leal, T. A., Dowell, J. E., Tsai, M. L., Dakhil, C. S. R., Stella, P., Jin, Y., Shames, D. S., Schleifman, E., Fabrizio, D. A., Phan, S. & Socinski, M. A., May 2022, In: Nature Medicine. 28, 5, p. 939-945 7 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
El-Shennawy, L., Hoffmann, A. D., Dashzeveg, N. K., McAndrews, K. M., Mehl, P. J., Cornish, D., Yu, Z., Tokars, V. L., Nicolaescu, V., Tomatsidou, A., Mao, C., Felicelli, C. J., Tsai, C. F., Ostiguin, C., Jia, Y., Li, L., Furlong, K., Wysocki, J., Luo, X., Ruivo, C. F., & 16 others, Dec 2022, In: Nature communications. 13, 1, 405.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations